Platelet-derived microparticles during and after acute coronary syndrome
Platelet-derived microparticles during and after acute coronary syndrome
复制标题
DOI：
10.1160/th11-11-0779
复制
发表时间：
2012-06-01
影响因子：
6.7
通讯作者：
Wallen, Hakan
中科院分区：
文献类型：
--
作者：
Skeppholm, Mika;Mobarrez, Fariborz;Wallen, Hakan
由于微粒在血小板激活时脱落，并可用于评估血小板功能，我们测量了急性冠脉综合征(ACS)期间和之后血浆中血小板衍生微粒(PMPs)的浓度。51例急性冠脉综合征患者在入院时、24小时内(冠状动脉造影术前)和6个月后进行了调查。对61名性别和年龄匹配的健康对照进行了一次调查。PMP被定义为颗粒
As microparticles are shedded upon platelet activation, and may be used to assess platelet function, we measured plasma concentrations of platelet-derived microparticles (PMPs) during and after an acute coronary syndrome (ACS). Fifty-one patients with ACS were investigated at admission, within 24 hours (before coronary angiography), and six months later. Sixty-one sex- and age-matched healthy controls were investigated once. PMPs were defined as particles